Profile
The whole picture, one page.
Identity, goals, genetics, protocol, and the latest bloodwork — the single source of truth that the bloodwork and protocols pages hang off of.
Updated 2026-07-12
- Age
- 38 (DOB 1988-05-08)
- Blood type
- O+ (not the universal donor — that’s O−)
- Location
- Hermosa Beach, CA
- Skin
- Fitzpatrick IV–VI — year-round vitamin D mandatory
- Training
- Sedentary — the single biggest untapped lever
Goals, ranked
Fertility / TTC
Gates everything. No TRT — fertility-preserving interventions only. Sperm is 50% of the equation.
Longevity
APOE e2/e2 — a rare, exceptional genetic hand. Invest in prevention while healthy.
Cognitive optimization
Overcome COMT Val/Val + DBH CC “dopamine desert” — a lifelong ADHD phenotype.
Muscle gain
Preserve lean mass through retatrutide. Biggest gap: no resistance training yet.
Fat loss
Retatrutide + tesofensine driving it; metabolically near-optimal already.
Focus right now — Sleep
Protocol #1. A 30-day Whoop block showed HRV ~20ms (bottom 5th percentile), RHR 84, and 5.6h average sleep. No new compounds until HRV clears 30 — sleep is also the #1 lever for sperm and recovery.
Genetics → dosing rules
Actionable variants only — each one drives a specific intervention.
| Gene | Genotype | Implication | Action |
|---|---|---|---|
| APOE | e2/e2 | Rare (~1%), longevity, low Alzheimer’s risk | Invest in prevention |
| MTHFR (+8 more) | C677T/A1298C het | 9-variant methylation defect | Methylfolate 15mg + B2 + TMG + injectable B12 |
| BCMO1 | reduced | Poor β-carotene→retinol conversion | Preformed retinol (retinol lab 68 ✓) |
| DIO2 | variant | Reduced T4→T3 conversion | Selenium 200mcg |
| VDR (+GC) | 4 variants | Higher vitamin D requirement × dark skin | D3 ~15k/day recovery dose (target 70–90) |
| PEMT | TT | Reduced choline synthesis | Alpha-GPC 300mg |
| FADS1/2 | het | ~50% reduced EPA/DHA conversion | Direct fish oil (Omega-3 index 3.7→9.9%) |
| NOS3 | CT | Lower baseline nitric oxide | Tadalafil 5mg daily + NO booster |
| COMT / DBH | Val/Val / CC | Prefrontal “dopamine desert” → ADHD | Tesofensine, Semax, Dihexa, 5-Amino-1MQ |
| SRD5A2 | CC | Higher DHT activity | Stinging nettle + topical RU58841 |
| GCLM / SOD2 | AG / GG | Low glutathione, mito oxidative stress | GlyNAC + injected glutathione; CoQ10 + PQQ |
| PTPN22 | hom alt | Major autoimmune risk (shared with partner) | Standing T-cell / autoimmune monitoring |
Active protocol
full stack →12
Active peptides / injectables
33
Supplements
TTC
Fertility-preserving — no TRT
Headliners: Retatrutide 5mg/wk · Enclomiphene 12.5mg + Kisspeptin (fertility-preserving T) · MOTS-c · GHK-Cu · Semax 3mg · NAD+ · a genetics-matched methylation and omega-3 stack.
Latest biomarkers
all markers →Optimized
- Triglycerides3864→38, optimal
- ApoB84sole lipid lever (target <80)
- Lipoprotein (a)21lifetime-low CV risk
- HbA1c5.1%reta glycemic control
- hs-CRP0.7Tier-1 inflammatory quiet
- TSH1.21clean thyroid, no antibodies
Watching
- Free Testosterone117mid-range; recheck wk 6–8 on enclomiphene
- SHBG60→51the enclomiphene “tax” — key lever
- Estradiol37under <40 target → hold aromatase inhibitor
- Vitamin D56↓ from 82 — dose rebuilt, retest ~8wk
Open threads
- Semen analysis — Legacy, ~mid-July — #1 fertility data gap (3mo on kisspeptin).
- July 16 follow-up panel — Steady-state E2 / Free T / SHBG / LH + Inhibin B.
- Start resistance training — Biggest lever across muscle, HRV, testosterone, and sperm.
- Sleep intervention — HRV must clear 30 before any new compounds.
- BRCA2 het — Genetic counseling referral still open.